Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice
Caffeine is a psychostimulant with positive effects on cognition. Recent studies have suggested the participation of the cholinergic system in the effects of caffeine on wakefulness. However, there are few studies assessing the contribution of cholinergic system in the cognitive enhancer properties...
Gespeichert in:
Veröffentlicht in: | Behavioural brain research 2010-12, Vol.214 (2), p.254-259 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 259 |
---|---|
container_issue | 2 |
container_start_page | 254 |
container_title | Behavioural brain research |
container_volume | 214 |
creator | Botton, Paulo Henrique Costa, Marcelo S. Ardais, Ana Paula Mioranzza, Sabrina Souza, Diogo O. da Rocha, João Batista Teixeira Porciúncula, Lisiane O. |
description | Caffeine is a psychostimulant with positive effects on cognition. Recent studies have suggested the participation of the cholinergic system in the effects of caffeine on wakefulness. However, there are few studies assessing the contribution of cholinergic system in the cognitive enhancer properties of caffeine. In the present study, the effects of a dose and schedule of administration of caffeine that improved memory recognition were investigated on scopolamine-induced impairment of memory in adult mice. Inhibitory avoidance and novel object recognition tasks were used to assess learning and memory. Caffeine (10
mg/kg, i.p.) was administered during 4 consecutive days, and the treatment was interrupted 24
h before scopolamine administration (2
mg/kg, i.p.). Scopolamine was administered prior to or immediately after training. Short-term and long-term memory was evaluated in both tasks. In the novel object recognition task, pre treatment with caffeine prevented the disruption of short- and long-term memory by scopolamine. In the inhibitory avoidance task, caffeine prevented short- but not long-term memory disruption by pre training administration of scopolamine. Caffeine prevented short- and long-term memory disruption by post training administration of scopolamine. Both treatments did not affect locomotor activity of the animals. These findings suggest that acute treatment with caffeine followed by its withdrawal may be effective against cholinergic-induced disruption of memory assessed in an aversive and non-aversive task. Finally, our results revealed that the cholinergic system is involved in the positive effects of caffeine on cognitive functions. |
doi_str_mv | 10.1016/j.bbr.2010.05.034 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_815533188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432810004080</els_id><sourcerecordid>815533188</sourcerecordid><originalsourceid>FETCH-LOGICAL-c550t-94f55a6c8e99ef0d02806d41bb4e8bd0b7014d3267fac468b4bd944ba5ddaf573</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROO3oA7gxbIyraqEKqqi4Mp3RMZnEja4JPxeHtgpKoDrpt_CRpadbZ-fqBu53DuQchF5TsqWE9u_3W63TtiX1TPiWdOwJ2lAxtM3A2fgUbSrTN6xrxRV6kfOeEMIIp8_RVUs474aeb9DvnXIOfAC8JDhAKBlbn9O6FB8Djg7PMMd0xCaGHCdv1cO9D7jcQx33Xvty2qtDrMtgAKtgcYgHmHDUezAFJzDxR_APwqLyz4z1EWcTlzip-fRydVN2nQqevYGX6JlTU4ZXl3mNvn-6-ba7be6-fv6y-3jXGM5JaUbmOFe9ETCO4IglrSC9ZVRrBkJbogdCme3afnDKsF5opu3ImFbcWuX40F2jd2ffJcVfK-QiZ58NTJMKENcsBa0RdVSIStIzaVLMOYGTS_KzSkdJiTz1IPey9iBPPUjCZe2hat5c3Fc9g_2n-Bt8Bd5eAJWNmlyq2fn8yHWUswpX7sOZg5rFwUOS2XioOVtfcy3SRv-fb_wBNhGpTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>815533188</pqid></control><display><type>article</type><title>Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Botton, Paulo Henrique ; Costa, Marcelo S. ; Ardais, Ana Paula ; Mioranzza, Sabrina ; Souza, Diogo O. ; da Rocha, João Batista Teixeira ; Porciúncula, Lisiane O.</creator><creatorcontrib>Botton, Paulo Henrique ; Costa, Marcelo S. ; Ardais, Ana Paula ; Mioranzza, Sabrina ; Souza, Diogo O. ; da Rocha, João Batista Teixeira ; Porciúncula, Lisiane O.</creatorcontrib><description>Caffeine is a psychostimulant with positive effects on cognition. Recent studies have suggested the participation of the cholinergic system in the effects of caffeine on wakefulness. However, there are few studies assessing the contribution of cholinergic system in the cognitive enhancer properties of caffeine. In the present study, the effects of a dose and schedule of administration of caffeine that improved memory recognition were investigated on scopolamine-induced impairment of memory in adult mice. Inhibitory avoidance and novel object recognition tasks were used to assess learning and memory. Caffeine (10
mg/kg, i.p.) was administered during 4 consecutive days, and the treatment was interrupted 24
h before scopolamine administration (2
mg/kg, i.p.). Scopolamine was administered prior to or immediately after training. Short-term and long-term memory was evaluated in both tasks. In the novel object recognition task, pre treatment with caffeine prevented the disruption of short- and long-term memory by scopolamine. In the inhibitory avoidance task, caffeine prevented short- but not long-term memory disruption by pre training administration of scopolamine. Caffeine prevented short- and long-term memory disruption by post training administration of scopolamine. Both treatments did not affect locomotor activity of the animals. These findings suggest that acute treatment with caffeine followed by its withdrawal may be effective against cholinergic-induced disruption of memory assessed in an aversive and non-aversive task. Finally, our results revealed that the cholinergic system is involved in the positive effects of caffeine on cognitive functions.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2010.05.034</identifier><identifier>PMID: 20553765</identifier><identifier>CODEN: BBREDI</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Acetylcholine ; Adenosine ; Adult and adolescent clinical studies ; Alzheimer's disease ; Animals ; Avoidance Learning - drug effects ; Behavioral psychophysiology ; Biological and medical sciences ; Caffeine ; Caffeine - administration & dosage ; Caffeine - pharmacology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Drug Administration Schedule ; Drug Interactions ; Fundamental and applied biological sciences. Psychology ; Learning and memory ; Male ; Medical sciences ; Memory - drug effects ; Mice ; Mice, Inbred Strains ; Motor Activity - drug effects ; Neurology ; Neuropharmacology ; Neuroprotection ; Object recognition ; Organic mental disorders. Neuropsychology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Psychopathology. Psychiatry ; Psychopharmacology ; Recognition (Psychology) - drug effects ; Scopolamine ; Scopolamine Hydrobromide - antagonists & inhibitors ; Scopolamine Hydrobromide - pharmacology</subject><ispartof>Behavioural brain research, 2010-12, Vol.214 (2), p.254-259</ispartof><rights>2010 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright (c) 2010 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c550t-94f55a6c8e99ef0d02806d41bb4e8bd0b7014d3267fac468b4bd944ba5ddaf573</citedby><cites>FETCH-LOGICAL-c550t-94f55a6c8e99ef0d02806d41bb4e8bd0b7014d3267fac468b4bd944ba5ddaf573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0166432810004080$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23154205$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20553765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Botton, Paulo Henrique</creatorcontrib><creatorcontrib>Costa, Marcelo S.</creatorcontrib><creatorcontrib>Ardais, Ana Paula</creatorcontrib><creatorcontrib>Mioranzza, Sabrina</creatorcontrib><creatorcontrib>Souza, Diogo O.</creatorcontrib><creatorcontrib>da Rocha, João Batista Teixeira</creatorcontrib><creatorcontrib>Porciúncula, Lisiane O.</creatorcontrib><title>Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>Caffeine is a psychostimulant with positive effects on cognition. Recent studies have suggested the participation of the cholinergic system in the effects of caffeine on wakefulness. However, there are few studies assessing the contribution of cholinergic system in the cognitive enhancer properties of caffeine. In the present study, the effects of a dose and schedule of administration of caffeine that improved memory recognition were investigated on scopolamine-induced impairment of memory in adult mice. Inhibitory avoidance and novel object recognition tasks were used to assess learning and memory. Caffeine (10
mg/kg, i.p.) was administered during 4 consecutive days, and the treatment was interrupted 24
h before scopolamine administration (2
mg/kg, i.p.). Scopolamine was administered prior to or immediately after training. Short-term and long-term memory was evaluated in both tasks. In the novel object recognition task, pre treatment with caffeine prevented the disruption of short- and long-term memory by scopolamine. In the inhibitory avoidance task, caffeine prevented short- but not long-term memory disruption by pre training administration of scopolamine. Caffeine prevented short- and long-term memory disruption by post training administration of scopolamine. Both treatments did not affect locomotor activity of the animals. These findings suggest that acute treatment with caffeine followed by its withdrawal may be effective against cholinergic-induced disruption of memory assessed in an aversive and non-aversive task. Finally, our results revealed that the cholinergic system is involved in the positive effects of caffeine on cognitive functions.</description><subject>Acetylcholine</subject><subject>Adenosine</subject><subject>Adult and adolescent clinical studies</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Avoidance Learning - drug effects</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Caffeine</subject><subject>Caffeine - administration & dosage</subject><subject>Caffeine - pharmacology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Drug Administration Schedule</subject><subject>Drug Interactions</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Learning and memory</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Motor Activity - drug effects</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Neuroprotection</subject><subject>Object recognition</subject><subject>Organic mental disorders. Neuropsychology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Recognition (Psychology) - drug effects</subject><subject>Scopolamine</subject><subject>Scopolamine Hydrobromide - antagonists & inhibitors</subject><subject>Scopolamine Hydrobromide - pharmacology</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2OFCEUhYnROO3oA7gxbIyraqEKqqi4Mp3RMZnEja4JPxeHtgpKoDrpt_CRpadbZ-fqBu53DuQchF5TsqWE9u_3W63TtiX1TPiWdOwJ2lAxtM3A2fgUbSrTN6xrxRV6kfOeEMIIp8_RVUs474aeb9DvnXIOfAC8JDhAKBlbn9O6FB8Djg7PMMd0xCaGHCdv1cO9D7jcQx33Xvty2qtDrMtgAKtgcYgHmHDUezAFJzDxR_APwqLyz4z1EWcTlzip-fRydVN2nQqevYGX6JlTU4ZXl3mNvn-6-ba7be6-fv6y-3jXGM5JaUbmOFe9ETCO4IglrSC9ZVRrBkJbogdCme3afnDKsF5opu3ImFbcWuX40F2jd2ffJcVfK-QiZ58NTJMKENcsBa0RdVSIStIzaVLMOYGTS_KzSkdJiTz1IPey9iBPPUjCZe2hat5c3Fc9g_2n-Bt8Bd5eAJWNmlyq2fn8yHWUswpX7sOZg5rFwUOS2XioOVtfcy3SRv-fb_wBNhGpTA</recordid><startdate>20101225</startdate><enddate>20101225</enddate><creator>Botton, Paulo Henrique</creator><creator>Costa, Marcelo S.</creator><creator>Ardais, Ana Paula</creator><creator>Mioranzza, Sabrina</creator><creator>Souza, Diogo O.</creator><creator>da Rocha, João Batista Teixeira</creator><creator>Porciúncula, Lisiane O.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20101225</creationdate><title>Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice</title><author>Botton, Paulo Henrique ; Costa, Marcelo S. ; Ardais, Ana Paula ; Mioranzza, Sabrina ; Souza, Diogo O. ; da Rocha, João Batista Teixeira ; Porciúncula, Lisiane O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c550t-94f55a6c8e99ef0d02806d41bb4e8bd0b7014d3267fac468b4bd944ba5ddaf573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acetylcholine</topic><topic>Adenosine</topic><topic>Adult and adolescent clinical studies</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Avoidance Learning - drug effects</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Caffeine</topic><topic>Caffeine - administration & dosage</topic><topic>Caffeine - pharmacology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Drug Administration Schedule</topic><topic>Drug Interactions</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Learning and memory</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Motor Activity - drug effects</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Neuroprotection</topic><topic>Object recognition</topic><topic>Organic mental disorders. Neuropsychology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Recognition (Psychology) - drug effects</topic><topic>Scopolamine</topic><topic>Scopolamine Hydrobromide - antagonists & inhibitors</topic><topic>Scopolamine Hydrobromide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Botton, Paulo Henrique</creatorcontrib><creatorcontrib>Costa, Marcelo S.</creatorcontrib><creatorcontrib>Ardais, Ana Paula</creatorcontrib><creatorcontrib>Mioranzza, Sabrina</creatorcontrib><creatorcontrib>Souza, Diogo O.</creatorcontrib><creatorcontrib>da Rocha, João Batista Teixeira</creatorcontrib><creatorcontrib>Porciúncula, Lisiane O.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Botton, Paulo Henrique</au><au>Costa, Marcelo S.</au><au>Ardais, Ana Paula</au><au>Mioranzza, Sabrina</au><au>Souza, Diogo O.</au><au>da Rocha, João Batista Teixeira</au><au>Porciúncula, Lisiane O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>2010-12-25</date><risdate>2010</risdate><volume>214</volume><issue>2</issue><spage>254</spage><epage>259</epage><pages>254-259</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><coden>BBREDI</coden><abstract>Caffeine is a psychostimulant with positive effects on cognition. Recent studies have suggested the participation of the cholinergic system in the effects of caffeine on wakefulness. However, there are few studies assessing the contribution of cholinergic system in the cognitive enhancer properties of caffeine. In the present study, the effects of a dose and schedule of administration of caffeine that improved memory recognition were investigated on scopolamine-induced impairment of memory in adult mice. Inhibitory avoidance and novel object recognition tasks were used to assess learning and memory. Caffeine (10
mg/kg, i.p.) was administered during 4 consecutive days, and the treatment was interrupted 24
h before scopolamine administration (2
mg/kg, i.p.). Scopolamine was administered prior to or immediately after training. Short-term and long-term memory was evaluated in both tasks. In the novel object recognition task, pre treatment with caffeine prevented the disruption of short- and long-term memory by scopolamine. In the inhibitory avoidance task, caffeine prevented short- but not long-term memory disruption by pre training administration of scopolamine. Caffeine prevented short- and long-term memory disruption by post training administration of scopolamine. Both treatments did not affect locomotor activity of the animals. These findings suggest that acute treatment with caffeine followed by its withdrawal may be effective against cholinergic-induced disruption of memory assessed in an aversive and non-aversive task. Finally, our results revealed that the cholinergic system is involved in the positive effects of caffeine on cognitive functions.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>20553765</pmid><doi>10.1016/j.bbr.2010.05.034</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0166-4328 |
ispartof | Behavioural brain research, 2010-12, Vol.214 (2), p.254-259 |
issn | 0166-4328 1872-7549 |
language | eng |
recordid | cdi_proquest_miscellaneous_815533188 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acetylcholine Adenosine Adult and adolescent clinical studies Alzheimer's disease Animals Avoidance Learning - drug effects Behavioral psychophysiology Biological and medical sciences Caffeine Caffeine - administration & dosage Caffeine - pharmacology Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Drug Administration Schedule Drug Interactions Fundamental and applied biological sciences. Psychology Learning and memory Male Medical sciences Memory - drug effects Mice Mice, Inbred Strains Motor Activity - drug effects Neurology Neuropharmacology Neuroprotection Object recognition Organic mental disorders. Neuropsychology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Psychopathology. Psychiatry Psychopharmacology Recognition (Psychology) - drug effects Scopolamine Scopolamine Hydrobromide - antagonists & inhibitors Scopolamine Hydrobromide - pharmacology |
title | Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T14%3A04%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caffeine%20prevents%20disruption%20of%20memory%20consolidation%20in%20the%20inhibitory%20avoidance%20and%20novel%20object%20recognition%20tasks%20by%20scopolamine%20in%20adult%20mice&rft.jtitle=Behavioural%20brain%20research&rft.au=Botton,%20Paulo%20Henrique&rft.date=2010-12-25&rft.volume=214&rft.issue=2&rft.spage=254&rft.epage=259&rft.pages=254-259&rft.issn=0166-4328&rft.eissn=1872-7549&rft.coden=BBREDI&rft_id=info:doi/10.1016/j.bbr.2010.05.034&rft_dat=%3Cproquest_cross%3E815533188%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=815533188&rft_id=info:pmid/20553765&rft_els_id=S0166432810004080&rfr_iscdi=true |